Artwork

Content provided by Australian Broadcasting Corporation and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Is Australia lagging behind in its approach to type 2 diabetes?

11:03
 
Share
 

Manage episode 492605092 series 2462950
Content provided by Australian Broadcasting Corporation and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

We might need an update to first-line treatment for type 2 diabetes, according to some experts.

In Australia metformin is the first-line treatment, with drugs called SGLT2 inhibitors considered a second-line approach if needed.

They work by increasing glucose excretion in the urine.

In the United States it’s common to use them as first-line treatment alongside metformin. Is that the right approach?

Guest/s

  • Dr Ted Wu, endocrinologist and director of the diabetes centre at the Royal Prince Alfred Hospital in Sydney
  continue reading

57 episodes

Artwork
iconShare
 
Manage episode 492605092 series 2462950
Content provided by Australian Broadcasting Corporation and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

We might need an update to first-line treatment for type 2 diabetes, according to some experts.

In Australia metformin is the first-line treatment, with drugs called SGLT2 inhibitors considered a second-line approach if needed.

They work by increasing glucose excretion in the urine.

In the United States it’s common to use them as first-line treatment alongside metformin. Is that the right approach?

Guest/s

  • Dr Ted Wu, endocrinologist and director of the diabetes centre at the Royal Prince Alfred Hospital in Sydney
  continue reading

57 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play